Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Jul 1996, 1779-1783, Vol 34, No. 7
PC Iwen, DM Kelly, J Linder and SH Hinrichs
The frequency of antimicrobial agent-resistant enterococci is increasing,
making accurate identification and screening for susceptibility essential.
We evaluated the ability of MicroScan Positive Breakpoint Combo Type 6
panels (Dade MicroScan Inc., West Sacramento, Calif.) to identify
Enterococcus species and to detect ampicillin and vancomycin resistance. A
total of 398 well-characterized Enterococcus isolates from two institutions
were inoculated into MicroScan panels, into conventional biochemical
assays, and into ampicillin and vancomycin agar dilution media. Resistance
was verified by the broth macrodilution method. MicroScan panels accurately
detected resistance to ampicillin in 132 of 132 enterococcal isolates,
while three isolates for which the MICs were < 16 micrograms/ml were
classified incorrectly by MicroScan panels as resistant. No beta-
lactamase-producing enterococci were detected. All 64 isolates showing
resistance to vancomycin (MICs > or = 32 micrograms/ml) were correctly
classified by MicroScan panels. Seven isolates for which the vancomycin
MICs were 8 and 16 micrograms/ml were incorrectly classified as susceptible
by MicroScan panels, while eight isolates for which the MICs were 4
micrograms/ml were incorrectly labeled as intermediate. Fourteen of these
15 isolates were subsequently identified as motile enterococci. Overall,
there were three major errors in susceptibility testing for ampicillin and
15 minor errors for vancomycin. Conventional testing confirmed the identity
of 181 Enterococcus faecalis isolates, 157 E. faecium isolates, and 60
isolates of other species; however, 56 of these 60 isolates were
misidentified by the MicroScan panels. After recognition of this problem, a
revised approach which included tests for pigment, motility, and sucrose
fermentation was devised. In combination with these additional assays, the
conventional MicroScan panels accurately identified the 56 originally
misidentified isolates. In summary, the ability of MicroScan panels to
detect vancomycin and ampicillin resistance in enterococci was confirmed.
Our study found that the inability of MicroScan panels to identify
enterococci other than E. faecalis and E. faecium can be compensated for by
the addition of standard assays.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198-6495, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»